A Patient with the GLA p.E66Q Mutation Exhibiting Vascular Parkinsonism and Bilateral Pulvinar Lesions

Intern Med. 2015;54(19):2503-6. doi: 10.2169/internalmedicine.54.4437. Epub 2015 Oct 1.

Abstract

A 76-year-old man was admitted to our hospital due to gait difficulty. Brain imaging indicated bilateral pulvinar lesions and moderate white matter lesions. The serum α-galactosidase A levels were measured for the differential diagnosis of bilateral pulvinar lesions and were found to be abnormally low. Therefore, the patient was suspected to have variant Fabry disease. A GLA mutation analysis showed the p.E66Q mutation, which is speculated to be a functional polymorphism rather than a disease-causing mutation of Fabry disease. Enzyme replacement therapy did not result in a marked improvement, however, the disease progression stopped.

Publication types

  • Case Reports

MeSH terms

  • DNA Mutational Analysis
  • Diagnosis, Differential
  • Disease Progression
  • Enzyme Replacement Therapy
  • Fabry Disease / blood
  • Fabry Disease / diagnosis
  • Fabry Disease / genetics*
  • Humans
  • Male
  • Middle Aged
  • Mutation / genetics
  • Parkinsonian Disorders / blood
  • Parkinsonian Disorders / etiology
  • Parkinsonian Disorders / genetics*
  • Pulvinar / pathology*
  • Risk Factors
  • Treatment Outcome
  • alpha-Galactosidase / blood*

Substances

  • GLA protein, human
  • alpha-Galactosidase